The results of the study indicate a significant effect on the composite index that was of only borderline significance for the individual outcome of mortality in the original report [ 2 ].
← all excerpts
Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial.
1
—
—